The purpose of this contract to support the activities required to produce, procure, store, ship, and maintain high-quality reagents, assays and or services in support of preclinical and clinical aids…
Active Definitive Contract Awarded Last action
- Contract number
- 75N93025C00011
- Awardee
-
Quality Biological Inc. UEI V7ACWSNAL845
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,780,359
Award facts
- Opportunity
-
- 75N93023000R19 Solicitation number
- Contract value 19% obligated
-
- $4,780,359.00 Current, with exercised options
- $25,374,525.00 Potential, with all options
- Completion date 23% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Montgomery Village, MD 20879, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $2,436,939 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,343,420 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $25.4 million definitive contract to Quality Biological Inc. for production, procurement, storage, and maintenance of reagents and assays supporting preclinical and clinical AIDS vaccine research on April 8, 2025, under a total small business set-aside. Quality Biological Inc. is a woman-owned, minority-owned small disadvantaged business.
The contract ceiling is $25,374,525 with a cost-plus-fixed-fee pricing structure. Performance runs through April 7, 2032, and is performed at the contractor's facility in Montgomery Village, Maryland. The contract supports activities to produce, procure, store, ship, and maintain high-quality reagents, assays, and related services in support of NIAID, NIH, and affiliated AIDS vaccine development initiatives under Executive Order 14398.
Description
The purpose of this contract to support the activities required to produce, procure, store, ship, and maintain high-quality reagents, assays and or services in support of preclinical and clinical aids vaccine research supported by niaid, NIH, and/or
Quick answers
Who was awarded contract 75N93025C00011?
75N93025C00011 was awarded to Quality Biological Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 8, 2025.
How much is contract 75N93025C00011 worth?
The government has obligated $4,780,359 on 75N93025C00011. Its potential value, with all options, is $25,374,525.
Was contract 75N93025C00011 competed?
The extent of competition for 75N93025C00011 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award